 |
 |
The recent interest in Sertoli Cells set bells ringing in my head, and sure enough, on checking back I see that almost exactly a year ago, the same subject was in all the news releases. The gist of the news was that Titan Pharmaceuticals had signed a 1.5 million US Dollars licensing agreemwnt with the South Florida College of Medicine to develop Sertoli cell technology. That agreement was supposed to last 2 years, so I wonder what has caused them to pop up now (They don't seem to be saying anything new). Do you think they may be running out of money too soon ? Regards, -- Brian Collins <[log in to unmask]>